231 related articles for article (PubMed ID: 27016691)
1. Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.
Green C; Zhang S
Alzheimers Dement; 2016 Jul; 12(7):776-85. PubMed ID: 27016691
[TBL] [Abstract][Full Text] [Related]
2. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
3. Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.
Green C; Handels R; Gustavsson A; Wimo A; Winblad B; Sköldunger A; Jönsson L
Alzheimers Dement; 2019 Oct; 15(10):1309-1321. PubMed ID: 31402324
[TBL] [Abstract][Full Text] [Related]
4. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
Morris JC
Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
[TBL] [Abstract][Full Text] [Related]
5. Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis.
Tariot PN; Boada M; Lanctôt KL; Hahn-Pedersen J; Dabbous F; Udayachalerm S; Raket LL; Halchenko Y; Michalak W; Weidner W; Cummings J
Alzheimers Res Ther; 2024 Feb; 16(1):36. PubMed ID: 38355706
[TBL] [Abstract][Full Text] [Related]
6. Souvenaid for Alzheimer's disease.
Burckhardt M; Watzke S; Wienke A; Langer G; Fink A
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD011679. PubMed ID: 33320335
[TBL] [Abstract][Full Text] [Related]
7. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
[TBL] [Abstract][Full Text] [Related]
8. Estimating Progression Rates Across the Spectrum of Alzheimer's Disease for Amyloid-Positive Individuals Using National Alzheimer's Coordinating Center Data.
Potashman M; Buessing M; Levitchi Benea M; Cummings J; Borson S; Pemberton-Ross P; Epstein AJ
Neurol Ther; 2021 Dec; 10(2):941-953. PubMed ID: 34431074
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MGEKN; Tabet N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
[TBL] [Abstract][Full Text] [Related]
10. Donepezil for dementia due to Alzheimer's disease.
Birks JS; Harvey RJ
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
[TBL] [Abstract][Full Text] [Related]
11. Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer's Coordinating Center Uniform Data Set.
Crowell V; Reyes A; Zhou SQ; Vassilaki M; Gsteiger S; Gustavsson A
BMC Neurol; 2023 Aug; 23(1):302. PubMed ID: 37580727
[TBL] [Abstract][Full Text] [Related]
12. A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information.
Steenland K; Zhao L; John SE; Goldstein FC; Levey A; Alvaro A;
J Alzheimers Dis; 2018; 63(4):1383-1393. PubMed ID: 29843232
[TBL] [Abstract][Full Text] [Related]
13. Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progression.
Green C; Shearer J; Ritchie CW; Zajicek JP
Value Health; 2011; 14(5):621-30. PubMed ID: 21839398
[TBL] [Abstract][Full Text] [Related]
14. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a community-based multidomain cognitive intervention program in patients with Alzheimer's disease.
Kim HJ; Yang Y; Oh JG; Oh S; Choi H; Kim KH; Kim SH
Geriatr Gerontol Int; 2016 Feb; 16(2):191-9. PubMed ID: 25656505
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
17. Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.
Reed C; Happich M; Raskin J; Tockhorn-Heidenreich A; Belger M
J Prev Alzheimers Dis; 2019; 6(2):90-99. PubMed ID: 30756115
[TBL] [Abstract][Full Text] [Related]
18. Impaired Cognitive Function is Associated with Motor Function and Activities of Daily Living in Mild to Moderate Alzheimer's Dementia.
Lee G
Curr Alzheimer Res; 2020; 17(7):680-686. PubMed ID: 32811414
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
